Karuna is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.
Our team is uniquely steeped in neuroscience – with extensive expertise in the research, development and commercialization of CNS agents – and has profound, first-hand clinical experience working with patients and caregivers. This experience and expertise has informed our belief that there is a need for differentiated treatments that can help patients as they navigate the challenges presented by these complex conditions.
Utilizing our extensive knowledge of neuroscience, we are pursuing novel pathways to develop medicines with the potential to make a meaningful difference in peoples’ lives. Our shared passion inspires us to collectively work toward a goal bigger than ourselves, and our team is motivated to study and deliver medicines that can offer substantial improvements to those living with schizophrenia, dementia-related psychosis and other psychiatric and neurological conditions.
Data Provided by Refinitiv. Minimum 15 minutes delayed.